Literature DB >> 2912894

Impaired antipneumococcal activity of bronchoalveolar lining material of neonatal rats.

J D Coonrod1, M C Jarrells.   

Abstract

Pulmonary clearance of inhaled pneumococci is markedly impaired in neonatal rats compared with that in adult rats. To determine whether this impairment is due to a deficiency of extracellular bactericidal factors, the antipneumococcal activity of free fatty acids (FFA) in lung surfactant and the levels of lysozyme and transferrin in lavage fluids were quantified. Surfactant from adult rats averaged 68 U of antipneumococcal activity per g (dry weight) of lung, compared with less than 0.25 U for rats less than 1 week old (P less than 0.001). The kinds of FFA in surfactant of neonatal and adult rats were essentially identical, and the antipneumococcal activity of highly purified FFA from surfactant of neonatal and adult rats was also the same. However, the quantity of FFA in surfactant varied significantly with age, and rats less than 3 weeks old had much lower levels of surfactant FFA than did adults (P less than 0.001). In addition, lavage fluids from neonatal rats inhibited the antipneumococcal activity of surfactant FFA more than lavage fluids from adults did (P less than 0.02). This inhibitory activity did not appear to be due to protein binding. Lavage fluids from neonates showed an age-related deficiency of lysozyme (P less than 0.001), but lysozyme appeared to play no role in pneumococcal killing by the surfactant fraction of lavage fluids in vitro. Transferrin levels in lavage fluids were similar for neonates and adults. It was concluded that lung surfactant from neonatal rats was deficient in antipneumococcal activity, due mostly to low levels of FFA and to a lesser degree to increased levels of inhibitor(s) in lavage fluids.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2912894      PMCID: PMC313105          DOI: 10.1128/iai.57.2.359-366.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  The development of glutathione S-transferase and glutathione peroxidase activities in human lung.

Authors:  A A Fryer; R Hume; R C Strange
Journal:  Biochim Biophys Acta       Date:  1986-10-01

2.  Group B streptococcal lung infection in neonatal rabbits.

Authors:  M Sherman; E Goldstein; W Lippert; R Wennberg
Journal:  Pediatr Res       Date:  1982-03       Impact factor: 3.756

3.  Secretion of lipoprotein lipase by macrophages in culture.

Authors:  J C Khoo; E M Mahoney; J L Witztum
Journal:  J Biol Chem       Date:  1981-07-25       Impact factor: 5.157

4.  Detection and partial characterization of antibacterial factor(s) in alveolar lining material of rats.

Authors:  J D Coonrod; K Yoneda
Journal:  J Clin Invest       Date:  1983-01       Impact factor: 14.808

5.  Early pulmonary granulocyte recruitment in response to Streptococcus pneumoniae.

Authors:  W C Vial; G B Toews; A K Pierce
Journal:  Am Rev Respir Dis       Date:  1984-01

6.  Lipoprotein lipase secretion by human monocyte-derived macrophages.

Authors:  A Chait; P H Iverius; J D Brunzell
Journal:  J Clin Invest       Date:  1982-02       Impact factor: 14.808

7.  Oxygen toxicity in neonatal and adult animals of various species.

Authors:  L Frank; J R Bucher; R J Roberts
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1978-11

8.  Circulating and storage neutrophil changes in experimental type II group B streptococcal sepsis.

Authors:  R D Christensen; A O Shigeoka; H R Hill; G Rothstein
Journal:  Pediatr Res       Date:  1980-06       Impact factor: 3.756

9.  Hydrogen peroxide kills Staphylococcus aureus by reacting with staphylococcal iron to form hydroxyl radical.

Authors:  J E Repine; R B Fox; E M Berger
Journal:  J Biol Chem       Date:  1981-07-25       Impact factor: 5.157

10.  Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia.

Authors:  E F Osserman; D P Lawlor
Journal:  J Exp Med       Date:  1966-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.